Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia Cells

Resistance of acute lymphoblastic leukemia (ALL) cells to chemotherapy, whether present at diagnosis or acquired during treatment, is a major cause of treatment failure. Primary ALL cells are accessible for drug sensitivity testing at the time of new diagnosis or at relapse, but there are major limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowland, Lauren, Smart, Brandon, Brown, Anthony, Dettorre, Gino M., Gocho, Yoshihiro, Hunt, Jeremy, Yang, Wenjian, Yoshimura, Satoshi, Reyes, Noemi, Du, Guoqing, John, August, Maxwell, Dylan, Stock, Wendy, Kornblau, Steven, Relling, Mary V., Inaba, Hiroto, Pui, Ching-Hon, Bourquin, Jean-Pierre, Karol, Seth E., Mullighan, Charles G., Evans, William E., Yang, Jun J., Crews, Kristine R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bio-Protocol 2023
Materias:
Methods Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415213/
https://www.ncbi.nlm.nih.gov/pubmed/37575398
http://dx.doi.org/10.21769/BioProtoc.4731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415213/
https://www.ncbi.nlm.nih.gov/pubmed/37575398
http://dx.doi.org/10.21769/BioProtoc.4731

Ejemplares similares